Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0175 | ||||
| Gene Name | SLC25A16 | ||||
| Protein Name | Graves disease carrier protein | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | D10S105E; GDA; GDC; Graves disease autoantigen; HGT.1; ML7; SLC25A16; Solute carrier family 25 member 16; hML7; Mitochondrial solute carrier protein homolog | ||||
| DT Family | Mitochondrial Carrier (MC) Family ; | ||||
| Function | This transporter required for the accumulation of coenzyme A in the mitochondrial matrix. | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Coenzyme A
|
Phase 3 | Drug Info | Hyperlipoproteinemia | 5C80 | [1] |
|
Drug-DT Affinity Assessed by Cell Line |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Coenzyme A | Phase 3 | Drug Info | Yeast cells-GDC | Km = 140 microM | [1] |
| References | |||||
| 1 | Biochemical characterization of a new mitochondrial transporter of dephosphocoenzyme A in Drosophila melanogaster. Biochim Biophys Acta Bioenerg. 2017 Feb;1858(2):137-146. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.